c-Met specific CAR-T cells as a targeted therapy for non-small cell lung cancer cell A549

Non-small cell lung cancer (NSCLC) is considered to be one of the most prevalent and fatal malignancies, with a poor survival rate. Chimeric antigen receptor T cell (CAR-T) cell therapy is one of the most exciting directions in the field of Cellular immunotherapy. Therefore, CAR-T cells that target...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Jingting, Long, Chirong, Zhang, Lu, Duan, Jiakang, Fan, Honglian, Chu, Fei, Li, Zhenghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161852/
https://www.ncbi.nlm.nih.gov/pubmed/35378051
http://dx.doi.org/10.1080/21655979.2022.2058149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161852/
https://www.ncbi.nlm.nih.gov/pubmed/35378051
http://dx.doi.org/10.1080/21655979.2022.2058149

Ejemplares similares